Manning-Bennett, A.T.; Cervesi, J.; Bandinelli, P.-A.; Sorich, M.J.; Hopkins, A.M.
Prognostic Associations of Concomitant Antibiotic Use in Patients with Advanced NSCLC Treated with Atezolizumab: Sensitivity Analysis of a Pooled Investigation of Five Randomised Control Trials. Biomedicines 2023, 11, 528.
https://doi.org/10.3390/biomedicines11020528
AMA Style
Manning-Bennett AT, Cervesi J, Bandinelli P-A, Sorich MJ, Hopkins AM.
Prognostic Associations of Concomitant Antibiotic Use in Patients with Advanced NSCLC Treated with Atezolizumab: Sensitivity Analysis of a Pooled Investigation of Five Randomised Control Trials. Biomedicines. 2023; 11(2):528.
https://doi.org/10.3390/biomedicines11020528
Chicago/Turabian Style
Manning-Bennett, Arkady T, Julie Cervesi, Pierre-Alain Bandinelli, Michael J Sorich, and Ashley M Hopkins.
2023. "Prognostic Associations of Concomitant Antibiotic Use in Patients with Advanced NSCLC Treated with Atezolizumab: Sensitivity Analysis of a Pooled Investigation of Five Randomised Control Trials" Biomedicines 11, no. 2: 528.
https://doi.org/10.3390/biomedicines11020528
APA Style
Manning-Bennett, A. T., Cervesi, J., Bandinelli, P.-A., Sorich, M. J., & Hopkins, A. M.
(2023). Prognostic Associations of Concomitant Antibiotic Use in Patients with Advanced NSCLC Treated with Atezolizumab: Sensitivity Analysis of a Pooled Investigation of Five Randomised Control Trials. Biomedicines, 11(2), 528.
https://doi.org/10.3390/biomedicines11020528
